beta-adrenergic receptor-mediated transactivation of EGFR decreases cardiomyocyte apoptosis through differential subcellular activation of ERK and Akt.pdf (1.17 MB)

beta-adrenergic receptor-mediated transactivation of EGFR decreases cardiomyocyte apoptosis through differential subcellular activation of ERK and Akt.pdf

Download (1.17 MB)
journal contribution
posted on 08.03.2019 by Laurel A. Grisanti, Jennifer A. Talarico, Rhonda L. Carter, Justine E. Yu, Ashley A. Repas, Scott W. Radcliffe, Hoang-ai Tang, Catherine A. Makarewich, Steven R. Houser, Douglas G. Tilley
β-Adrenergic receptor (βAR)-mediated transactivation of epidermal growth factor receptor (EGFR) has been
shown to relay pro-survival effects via unknown mechanisms. We hypothesized that acute βAR-mediated
EGFR transactivation in the heart promotes differential subcellular activation of ERK1/2 and Akt, promoting
cell survival through modulation of apoptosis. C57BL/6 mice underwent acute i.p. injection with isoproterenol
(ISO)±AG 1478 (EGFR antagonist) to assess the impact of βAR-mediated EGFR transactivation on the phosphorylation
of ERK1/2 (P-ERK1/2) and Akt (P-Akt) in distinct cardiac subcellular fractions. Increased P-ERK1/2 and
P-Akt were observed in cytosolic, plasma membrane and nuclear fractions following ISO stimulation. Whereas
the P-ERK1/2 response was EGFR-sensitive in all fractions, the P-Akt response was EGFR-sensitive only in the
plasma membrane and nucleus, results confirmed in primary rat neonatal cardiomyocytes (RNCM). βARmediated
EGFR-transactivation also decreased apoptosis in serum-depleted RNCM, as measured via TUNEL as
well as caspase 3 activity/cleavage, which were sensitive to the inhibition of either ERK1/2 (PD184352) or Akt
(LY-294002) signaling. Caspase 3 activity/cleavage was also sensitive to the inhibition of transcription, which,
with an increase in nuclear P-ERK1/2 and P-Akt in response to ISO, suggested that βAR-mediated EGFR
transactivation may regulate apoptotic gene transcription. An Apoptosis PCR Array identified tnfsf10 (TRAIL) to
be altered by ISO in an EGFR-sensitive manner, results confirmed via RT-PCR and ELISA measurement of both
membrane-bound and soluble cardiomyocyte TRAIL levels. βAR-mediated EGFR transactivation induces differential
subcellular activation of ERK1/2 and Akt leading to increased cell survival through themodulation of caspase
3 activity and apoptotic gene expression in cardiomyocytes.

History

Grant ID

13POST16510022

Licence

Exports

Logo branding

Licence

Exports